Large-scale testing (Phase 3)Study completedNCT00654485
What this trial is testing
COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
Who this might be right for
Metabolic Syndrome
AstraZeneca 940